vs

Side-by-side financial comparison of Black Rock Coffee Bar, Inc. (BRCB) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

Black Rock Coffee Bar, Inc. is the larger business by last-quarter revenue ($51.5M vs $34.2M, roughly 1.5× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -1.4%, a 60.2% gap on every dollar of revenue. PRECISION BIOSCIENCES INC produced more free cash flow last quarter ($-11.3M vs $-25.8M).

Black Rock Coffee Bar, Inc. is a U.S.-based specialty coffee retail chain that offers handcrafted premium coffee beverages, energy drinks, baked goods, and light snacks. It operates in-store and drive-thru locations primarily across western U.S. states, prioritizing high-quality customizable products and community-focused consumer experiences.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BRCB vs DTIL — Head-to-Head

Bigger by revenue
BRCB
BRCB
1.5× larger
BRCB
$51.5M
$34.2M
DTIL
Higher net margin
DTIL
DTIL
60.2% more per $
DTIL
58.9%
-1.4%
BRCB
More free cash flow
DTIL
DTIL
$14.6M more FCF
DTIL
$-11.3M
$-25.8M
BRCB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BRCB
BRCB
DTIL
DTIL
Revenue
$51.5M
$34.2M
Net Profit
$-712.0K
$20.1M
Gross Margin
Operating Margin
-12.4%
36.6%
Net Margin
-1.4%
58.9%
Revenue YoY
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$-0.05
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRCB
BRCB
DTIL
DTIL
Q4 25
$34.2M
Q3 25
$51.5M
$13.0K
Q2 25
$18.0K
Q1 25
$29.0K
Q4 24
$638.0K
Q3 24
$576.0K
Q2 24
$49.9M
Q1 24
$17.6M
Net Profit
BRCB
BRCB
DTIL
DTIL
Q4 25
$20.1M
Q3 25
$-712.0K
$-21.8M
Q2 25
$-23.5M
Q1 25
$-20.6M
Q4 24
Q3 24
$-16.4M
Q2 24
$32.7M
Q1 24
$8.6M
Operating Margin
BRCB
BRCB
DTIL
DTIL
Q4 25
36.6%
Q3 25
-12.4%
-158976.9%
Q2 25
-121538.9%
Q1 25
-76248.3%
Q4 24
Q3 24
-3693.6%
Q2 24
48.4%
Q1 24
-23.8%
Net Margin
BRCB
BRCB
DTIL
DTIL
Q4 25
58.9%
Q3 25
-1.4%
-167476.9%
Q2 25
-130666.7%
Q1 25
-70913.8%
Q4 24
Q3 24
-2851.6%
Q2 24
65.6%
Q1 24
48.8%
EPS (diluted)
BRCB
BRCB
DTIL
DTIL
Q4 25
$2.62
Q3 25
$-0.05
$-1.84
Q2 25
$-2.13
Q1 25
$-2.21
Q4 24
Q3 24
$-2.25
Q2 24
$4.67
Q1 24
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRCB
BRCB
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$32.6M
$115.6M
Total DebtLower is stronger
$20.0M
Stockholders' EquityBook value
$43.0M
$92.2M
Total Assets
$323.2M
$154.4M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRCB
BRCB
DTIL
DTIL
Q4 25
$115.6M
Q3 25
$32.6M
$44.9M
Q2 25
$62.2M
Q1 25
$77.2M
Q4 24
$86.3M
Q3 24
$101.2M
Q2 24
$123.6M
Q1 24
$137.8M
Total Debt
BRCB
BRCB
DTIL
DTIL
Q4 25
Q3 25
$20.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BRCB
BRCB
DTIL
DTIL
Q4 25
$92.2M
Q3 25
$43.0M
$16.6M
Q2 25
$34.1M
Q1 25
$49.3M
Q4 24
$56.4M
Q3 24
$64.9M
Q2 24
$74.7M
Q1 24
$37.2M
Total Assets
BRCB
BRCB
DTIL
DTIL
Q4 25
$154.4M
Q3 25
$323.2M
$93.5M
Q2 25
$108.9M
Q1 25
$124.4M
Q4 24
$136.4M
Q3 24
$153.3M
Q2 24
$165.8M
Q1 24
$184.7M
Debt / Equity
BRCB
BRCB
DTIL
DTIL
Q4 25
Q3 25
0.46×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRCB
BRCB
DTIL
DTIL
Operating Cash FlowLast quarter
$-2.9M
$-11.3M
Free Cash FlowOCF − Capex
$-25.8M
$-11.3M
FCF MarginFCF / Revenue
-50.2%
-32.9%
Capex IntensityCapex / Revenue
44.5%
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRCB
BRCB
DTIL
DTIL
Q4 25
$-11.3M
Q3 25
$-2.9M
$-15.3M
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.4M
Q3 24
$-5.9M
Q2 24
$-14.9M
Q1 24
$-19.0M
Free Cash Flow
BRCB
BRCB
DTIL
DTIL
Q4 25
$-11.3M
Q3 25
$-25.8M
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
BRCB
BRCB
DTIL
DTIL
Q4 25
-32.9%
Q3 25
-50.2%
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
BRCB
BRCB
DTIL
DTIL
Q4 25
0.1%
Q3 25
44.5%
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
BRCB
BRCB
DTIL
DTIL
Q4 25
-0.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons